INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 439m ago
HOUSE PTR39m ago
SEC 13F39m ago
ROBINHOOD CHAIN38m ago
Corporate insider
HM

Hopman Mark

Chief Commercial OfficerCIK 0002048497

EDGAR filingsOpen in network
Disclosed transactions14
Buys / sells0 / 14
Max Insider Score35
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
3
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$6,253
370 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Beta Bionics, Inc.Chief Commercial Officer · Mar 5, 2026
3
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL
$16K
821 sh
Oct 26, 2026
Oct 28, 2026
traded Oct 26, 2026
+2d
SEC FORM 4

Evidence

19
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale
SELL$13K
775 sh
Oct 14, 2026Oct 16, 2026
traded Oct 14, 2026
+2dSEC FORM 4

Evidence

19
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale
SELL$7,015
370 sh
Oct 1, 2026Oct 5, 2026
traded Oct 1, 2026
+4dSEC FORM 4

Evidence

27
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$620K
30.8K sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC FORM 4

Evidence

13
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$12K
775 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC FORM 4

Evidence

27
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$681K
36.9K sh
Sep 9, 2026Sep 10, 2026
traded Sep 9, 2026
+1dSEC FORM 4

Evidence

32
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale
SELL$102K
5,327 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC FORM 4

Evidence

11
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$19K
1,258 sh
Jun 24, 2026Jun 25, 2026
traded Jun 24, 2026
+1dSEC FORM 4

Evidence

16
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$3,385
275 sh
Jun 4, 2026Jun 5, 2026
traded Jun 4, 2026
+1dSEC FORM 4

Evidence

35
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale
SELL$67K
5,329 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC FORM 4

Evidence

35
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$25K
856 sh
Dec 2, 2025Mar 16, 2026
traded Dec 2, 2025
+104dSEC FORM 4

Evidence

34
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$63K
2,061 sh
Dec 4, 2025Mar 16, 2026
traded Dec 4, 2025
+102dSEC FORM 4

Evidence

1
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$4,084
353 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC FORM 4

Evidence